GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MYND Life Sciences Inc (XCNQ:MYND) » Definitions » Price-to-Free-Cash-Flow

MYND Life Sciences (XCNQ:MYND) Price-to-Free-Cash-Flow : N/A (As of May. 12, 2025)


View and export this data going back to 2021. Start your Free Trial

What is MYND Life Sciences Price-to-Free-Cash-Flow?

As of today (2025-05-12), MYND Life Sciences's share price is C$0.07. MYND Life Sciences's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jul. 2024 was C$-0.00. Hence, MYND Life Sciences's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for MYND Life Sciences's Price-to-Free-Cash-Flow or its related term are showing as below:

XCNQ:MYND's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 29.405
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

MYND Life Sciences's Free Cash Flow per Share for the three months ended in Jul. 2024 was C$0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was C$-0.00.


MYND Life Sciences Price-to-Free-Cash-Flow Historical Data

The historical data trend for MYND Life Sciences's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MYND Life Sciences Price-to-Free-Cash-Flow Chart

MYND Life Sciences Annual Data
Trend Oct21 Oct22 Oct23
Price-to-Free-Cash-Flow
- - -

MYND Life Sciences Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of MYND Life Sciences's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, MYND Life Sciences's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MYND Life Sciences's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MYND Life Sciences's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where MYND Life Sciences's Price-to-Free-Cash-Flow falls into.


;
;

MYND Life Sciences Price-to-Free-Cash-Flow Calculation

MYND Life Sciences's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.07/-0.004
=N/A

MYND Life Sciences's Share Price of today is C$0.07.
MYND Life Sciences's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

MYND Life Sciences  (XCNQ:MYND) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


MYND Life Sciences Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of MYND Life Sciences's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


MYND Life Sciences Business Description

Traded in Other Exchanges
Address
105-2248 Elgin Avenue, Port Coquitlam, BC, CAN, V3C 2B2
MYND Life Sciences Inc is a medical biotech drug research and development company. The company is focused on neuro pharmaceutical and novel drug development, diagnostics, and vaccines and is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other (bio)pharmaceutical companies by different molecular concepts for the applications of psilocybin analogs for overcoming diseases.